Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy.

Sher DJ, Thotakura V, Balboni TA, Norris CM, Haddad RI, Posner MR, Lorch J, Goguen LA, Annino DJ, Tishler RB.

Ann Oncol. 2012 Sep;23(9):2391-8. doi: 10.1093/annonc/mdr609. Epub 2012 Mar 16.

PMID:
22425872
2.

Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy.

Sher DJ, Thotakura V, Balboni TA, Norris CM Jr, Haddad RI, Posner MR, Lorch J, Goguen LA, Annino DJ, Tishler RB.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e215-22. doi: 10.1016/j.ijrobp.2011.02.023. Epub 2011 Apr 29.

PMID:
21531515
3.

Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.

Trosman SJ, Koyfman SA, Ward MC, Al-Khudari S, Nwizu T, Greskovich JF, Lamarre ED, Scharpf J, Khan MJ, Lorenz RR, Adelstein DJ, Burkey BB.

JAMA Otolaryngol Head Neck Surg. 2015 May 1;141(5):457-62. doi: 10.1001/jamaoto.2015.136. Erratum in: JAMA Otolaryngol Head Neck Surg. 2015 May 1;141(5):428.

PMID:
25742025
4.

The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.

Zumsteg ZS, Lok BH, Ho AS, Drill E, Zhang Z, Riaz N, Shiao SL, Ma J, McBride SM, Tsai CJ, Baxi SS, Sherman EJ, Lee NY.

Cancer. 2017 Apr 15;123(8):1345-1353. doi: 10.1002/cncr.30495. Epub 2016 Dec 16.

PMID:
27984656
5.

Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy.

Roskies M, Kay-Rivest E, Mascarella MA, Sultanem K, Mlynarek A, Hier M.

J Otolaryngol Head Neck Surg. 2016 Oct 10;45(1):50.

6.

Target volume definition for intensity-modulated radiotherapy after induction chemotherapy and patterns of treatment failure after sequential chemoradiotherapy in locoregionally advanced oropharyngeal squamous cell carcinoma.

Loo SW, Geropantas K, Wilson P, Martin WM, Roques TW.

Clin Oncol (R Coll Radiol). 2013 Mar;25(3):162-70. doi: 10.1016/j.clon.2012.07.015. Epub 2012 Aug 18.

PMID:
22906546
7.

Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma.

Clavel S, Nguyen DH, Fortin B, Després P, Khaouam N, Donath D, Soulières D, Guertin L, Nguyen-Tan PF.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):582-9. doi: 10.1016/j.ijrobp.2010.10.061. Epub 2011 Feb 1.

PMID:
21277695
8.

Long-term outcomes of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma treated with IMRT: a retrospective study.

Su Z, Mao YP, Tang J, Lan XW, OuYang PY, Xie FY.

Tumour Biol. 2016 Apr;37(4):4429-38. doi: 10.1007/s13277-015-4266-5. Epub 2015 Oct 25.

PMID:
26499947
9.

Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol.

Habl G, Jensen AD, Potthoff K, Uhl M, Hof H, Hajda J, Simon C, Debus J, Krempien R, Münter MW.

BMC Cancer. 2010 Nov 26;10:651. doi: 10.1186/1471-2407-10-651.

10.

Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.

Hoffmann M, Saleh-Ebrahimi L, Zwicker F, Haering P, Schwahofer A, Debus J, Huber PE, Roeder F.

Radiat Oncol. 2015 Dec 4;10:251. doi: 10.1186/s13014-015-0561-y.

11.

Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.

Frakes JM, Naghavi AO, Demetriou SK, Strom TJ, Russell JS, Kish JA, McCaffrey JC, Otto KJ, Padhya TA, Harrison LB, Trotti AM, Caudell JJ.

Cancer. 2016 Feb 15;122(4):634-41. doi: 10.1002/cncr.29782. Epub 2015 Nov 13.

12.

Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.

Spreafico A, Huang SH, Xu W, Granata R, Liu CS, Waldron JN, Chen E, Ringash J, Bayley A, Chan KK, Hope AJ, Cho J, Razak AA, Hansen A, Jang R, Perez-Ordonez B, Weinreb I, Bossi P, Orlandi E, Licitra LF, Song Y, O'Sullivan B, Siu LL, Kim J.

Eur J Cancer. 2016 Nov;67:174-182. doi: 10.1016/j.ejca.2016.08.013. Epub 2016 Sep 24.

PMID:
27669504
13.

Concurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: analysis of treatment results and prognostic factors.

Krstevska V, Stojkovski I, Zafirova-Ivanovska B.

Radiat Oncol. 2012 May 28;7:78. doi: 10.1186/1748-717X-7-78.

14.

HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.

Nichols AC, Faquin WC, Westra WH, Mroz EA, Begum S, Clark JR, Rocco JW.

Otolaryngol Head Neck Surg. 2009 Feb;140(2):228-34. doi: 10.1016/j.otohns.2008.11.025.

PMID:
19201294
15.

Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer - a retrospective single center analysis.

Saleh-Ebrahimi L, Zwicker F, Muenter MW, Bischof M, Lindel K, Debus J, Huber PE, Roeder F.

Radiat Oncol. 2013 Jan 24;8:20. doi: 10.1186/1748-717X-8-20.

16.

Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer.

Koutcher L, Sherman E, Fury M, Wolden S, Zhang Z, Mo Q, Stewart L, Schupak K, Gelblum D, Wong R, Kraus D, Shah J, Zelefsky M, Pfister D, Lee N.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):915-22. doi: 10.1016/j.ijrobp.2010.07.008. Epub 2010 Oct 13.

PMID:
20947269
17.

Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomes.

Bledsoe TJ, Noble AR, Hunter GK, Rybicki LA, Hoschar A, Chute DJ, Saxton JP, Greskovich JF, Adelstein DJ, Koyfman SA.

Radiat Oncol. 2013 Jul 9;8:174. doi: 10.1186/1748-717X-8-174.

18.

It is not just IMRT: Human papillomavirus related oropharynx squamous cell carcinoma is associated with better swallowing outcomes after definitive chemoradiotherapy.

Naik M, Ward MC, Bledsoe TJ, Kumar AM, Rybicki LA, Saxton JP, Burkey BB, Greskovich JF, Adelstein DJ, Koyfman SA.

Oral Oncol. 2015 Aug;51(8):800-4. doi: 10.1016/j.oraloncology.2015.04.008. Epub 2015 May 11.

PMID:
25977228
19.

Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.

Inohara H, Takenaka Y, Yoshii T, Nakahara S, Yamamoto Y, Tomiyama Y, Seo Y, Isohashi F, Suzuki O, Yoshioka Y, Sumida I, Ogawa K.

Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):934-41. doi: 10.1016/j.ijrobp.2014.12.032.

PMID:
25832686
20.

Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer.

Hasegawa M, Maeda H, Deng Z, Kiyuna A, Ganaha A, Yamashita Y, Matayoshi S, Agena S, Toita T, Uehara T, Suzuki M.

Int J Oncol. 2014 Sep;45(3):1017-26. doi: 10.3892/ijo.2014.2504. Epub 2014 Jun 18.

Supplemental Content

Support Center